Drug Report History #234555
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v9-FR | Version v2-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated (Changed) | Updated to: 2024-12-04 | Was: 2024-08-05 |
| Drug Identification Number (Changed) | Updated to: 02516225 | Was: 02517701 |
| Brand name (Changed) | Updated to: SODIUM BICARBONATE INJECTION USP | Was: JAMP MIDODRINE |
| Common or Proper name (Changed) | Updated to: Sodium Bicarbonate Injection USP | Was: Midodrine Hydrochloride Tablets USP |
| Company Name | JAMP PHARMA CORPORATION | JAMP PHARMA CORPORATION |
| Ingredients (Changed) | Updated to: SODIUM BICARBONATE | Was: MIDODRINE HYDROCHLORIDE |
| Strength(s) (Changed) | Updated to: 84MG | Was: 2.5MG |
| Dosage form(s) (Changed) | Updated to: SOLUTION | Was: TABLET |
| Route of administration (Changed) | Updated to: INTRAVENOUS | Was: ORAL |
| Packaging size (Changed) | Updated to: 10x50mL | Was: 100 |
| Additional packaging sizes | ||
| ATC code (Changed) | Updated to: B05XA | Was: C01CA |
| ATC description (Changed) | Updated to: I.V. SOLUTION ADDITIVES | Was: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage (Changed) | Updated to: Demand increase for the drug. | Was: Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date (Changed) | Updated to: 2024-08-05 | Was: 2024-08-02 |
| Estimated end date (Changed) | Updated to: 2024-12-13 | Was: Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Allocation | Was: |
| Health Canada comments |